Galli E, Pedone MP, Dobreva M, et al. [Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]. Farmeconomia. Health Economics and Therapeutic Pathways. 2022;23(1). https://doi.org/10.7175/fe.v23i1.1527